Global NK Cells Market By Product Type (Mogamulizumab, Lorvotuzumab Mertansine) And By End-Users/Application (Cancer, Cardiovascular Diseases) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the NK Cells market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on NK Cells market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of NK Cells industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the NK Cells ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the NK Cells market.

The following manufacturers are covered in this report:
  • Chipscreen Biosciences
  • Affimed NV
  • Altor BioScience
  • Innate Pharma
  • Takeda
  • Sorrento Therapeutics
  • NantKwest
  • Bristol-Myers Squibb
  • NKT
  • Henry Ford Health Services
  • Fortress Biotech

The report estimates on the NK Cells market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global NK Cells market report consist of all leading industry players, NK Cells business sections, company profile, revenue supply by NK Cells industry sections, global NK Cells market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the NK Cells market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the NK Cells market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on NK Cells market, global analysis, different challenges or threats and opportunities for stakeholders involved in the NK Cells market.

Report Opportunity: Global NK Cells Market

This report delivers an analytical examination of the NK Cells market summarized in broad sections such as
  1. NK Cells Market Summary
  2. Key Commercial Growths in the NK Cells Industry
  3. Market Dynamics Affecting the NK Cells Industry
  4. Important Market Trends and Future Development Scenario of the NK Cells Market
  5. NK Cells Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of NK Cells Industry
  7. Positioning of Main Market Players in the NK Cells Industry
  8. NK Cells Market Revenue and Forecast, by Application, 2018 - 2028
  9. NK Cells Market Revenue and Forecast, by End-use, 2018 - 2028
  10. NK Cells Market Revenue and Forecast, by Geography, 2018 - 2028
NK Cells Market Segmentation:

The report provides detailed examination of the NK Cells market on the basis of various segments such as type, application and end-use industry. The NK Cells market is segmented as follows:

NK Cells Market, by Type:
  • Mogamulizumab
  • Lorvotuzumab Mertansine
  • Others
NK Cells Market, by Application:
  • Cancer
  • Cardiovascular Diseases
  • Others
Geographic Coverage

The report on the NK Cells market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America NK Cells Market Revenue and Forecast
  • U.S.
  • Canada
Europe NK Cells Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific NK Cells Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America NK Cells Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa NK Cells Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global NK Cells Market Snapshot
          2.1.1. Global NK Cells Market By Type,2019
               2.1.1.1.Mogamulizumab
               2.1.1.2.Lorvotuzumab Mertansine
               2.1.1.3.Others
          2.1.2. Global NK Cells Market By Application,2019
               2.1.2.1.Cancer
               2.1.2.2.Cardiovascular Diseases
               2.1.2.3.Others
          2.1.3. Global NK Cells Market By End-use,2019
          2.1.4. Global NK Cells Market By Geography,2019

3. Global NK Cells Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global NK Cells Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global NK Cells Market Size (US$), By Type, 2018 – 2028

5. Global NK Cells Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global NK Cells Market Size (US$), By Application, 2018 – 2028

6. Global NK Cells Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global NK Cells Market Size (US$), By End-use, 2018 – 2028

7. Global NK Cells Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America NK Cells Market Analysis, 2018 – 2028 
          7.2.1. North America NK Cells Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America NK Cells Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America NK Cells Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America NK Cells Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe NK Cells Market Analysis, 2018 – 2028 
          7.3.1.  Europe NK Cells Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe NK Cells Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe NK Cells Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe NK Cells Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific NK Cells Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific NK Cells Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific NK Cells Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific NK Cells Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific NK Cells Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America NK Cells Market Analysis, 2018 – 2028 
          7.5.1.  Latin America NK Cells Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America NK Cells Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America NK Cells Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America NK Cells Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) NK Cells Market Analysis, 2018 – 2028 
          7.6.1.  MEA NK Cells Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA NK Cells Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA NK Cells Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA NK Cells Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key NK Cells Providers
        8.4.1 Chipscreen Biosciences
                8.1.1 Business Description
                8.1.2 Chipscreen Biosciences Geographic Operations
                8.1.3 Chipscreen Biosciences Financial Information
                8.1.4 Chipscreen Biosciences Product Positions/Portfolio
                8.1.5 Chipscreen Biosciences Key Developments
        8.4.2 Affimed NV
                8.2.1 Business Description
                8.2.2 Affimed NV Geographic Operations
                8.2.3 Affimed NV Financial Information
                8.2.4 Affimed NV Product Positions/Portfolio
                8.2.5 Affimed NV Key Developments
        8.4.3 Altor BioScience
                8.3.1 Business Description
                8.3.2 Altor BioScience Geographic Operations
                8.3.3 Altor BioScience Financial Information
                8.3.4 Altor BioScience Product Positions/Portfolio
                8.3.5 Altor BioScience Key Developments
        8.4.4 Innate Pharma
                8.4.1 Business Description
                8.4.2 Innate Pharma Geographic Operations
                8.4.3 Innate Pharma Financial Information
                8.4.4 Innate Pharma Product Positions/Portfolio
                8.4.5 Innate Pharma Key Developments
        8.4.5 Takeda
                8.5.1 Business Description
                8.5.2 Takeda Geographic Operations
                8.5.3 Takeda Financial Information
                8.5.4 Takeda Product Positions/Portfolio
                8.5.5 Takeda Key Developments
        8.4.6 Sorrento Therapeutics
                8.6.1 Business Description
                8.6.2 Sorrento Therapeutics Geographic Operations
                8.6.3 Sorrento Therapeutics Financial Information
                8.6.4 Sorrento Therapeutics Product Positions/Portfolio
                8.6.5 Sorrento Therapeutics Key Developments
        8.4.7 NantKwest
                8.7.1 Business Description
                8.7.2 NantKwest Geographic Operations
                8.7.3 NantKwest Financial Information
                8.7.4 NantKwest Product Positions/Portfolio
                8.7.5 NantKwest Key Developments
        8.4.8 Bristol-Myers Squibb
                8.8.1 Business Description
                8.8.2 Bristol-Myers Squibb Geographic Operations
                8.8.3 Bristol-Myers Squibb Financial Information
                8.8.4 Bristol-Myers Squibb Product Positions/Portfolio
                8.8.5 Bristol-Myers Squibb Key Developments
        8.4.9 NKT
                8.9.1 Business Description
                8.9.2 NKT Geographic Operations
                8.9.3 NKT Financial Information
                8.9.4 NKT Product Positions/Portfolio
                8.9.5 NKT Key Developments
        8.4.10 Henry Ford Health Services
                8.10.1 Business Description
                8.10.2 Henry Ford Health Services Geographic Operations
                8.10.3 Henry Ford Health Services Financial Information
                8.10.4 Henry Ford Health Services Product Positions/Portfolio
                8.10.5 Henry Ford Health Services Key Developments
        8.4.11 Fortress Biotech
                8.11.1 Business Description
                8.11.2 Fortress Biotech Geographic Operations
                8.11.3 Fortress Biotech Financial Information
                8.11.4 Fortress Biotech Product Positions/Portfolio
                8.11.5 Fortress Biotech Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global NK Cells Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America NK Cells Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America NK Cells Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America NK Cells Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe NK Cells Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe NK Cells Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe NK Cells Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific NK Cells Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific NK Cells Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific NK Cells Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America NK Cells Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America NK Cells Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America NK Cells Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA NK Cells Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA NK Cells Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA NK Cells Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global NK Cells: Market Segmentation 
FIG. 2 Global NK Cells Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global NK Cells Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global NK Cells Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global NK Cells Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global NK Cells Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global NK Cells Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key NK Cells Providers, 2019
FIG. 11 Global NK Cells Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global NK Cells Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global NK Cells Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America NK Cells Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe NK Cells Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific NK Cells Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America NK Cells Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA NK Cells Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the NK Cells market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
5236

2016

OUR CLIENT